<div id="readability-page-1"><div><p><span>Schneyer Mark C Chief Financial Officer of Acadia Pharmaceuticals Inc [ACAD] filed a Form 4 on November 19, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>11/17/25</span></td><td><span>Exercise</span></td><td><span>19,826</span></td><td><span>$0.00</span></td><td><span>N/A</span></td></tr><tr><td><span>11/18/25</span></td><td><span>Planned Surrender(1)(2)</span></td><td><span>10,262</span></td><td><span>$23.69</span></td><td><span>$243,114</span></td></tr></tbody></table></div><p><span>Ending Holdings: 53,338 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</span></td></tr><tr><td><span>(2)</span></td><td><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

ACAD

<p>CFO Mark C. Schneyer of Acadia Pharmaceuticals Inc filed a Form 4 with the SEC, disclosing changes in ownership. On November 17, 2025, he exercised 19,826 shares, and on November 18, 2025, he surrendered 10,262 shares at $23.69 each, valued at $243,114, under a prearranged trading plan. His ending holdings are 53,338 shares directly.</p>

CFO Schneyer Acquires 9,564 Of Acadia Pharmaceuticals Inc [ACAD]